scispace - formally typeset
F

Fumihide Ogawa

Researcher at Nagasaki University

Publications -  110
Citations -  3155

Fumihide Ogawa is an academic researcher from Nagasaki University. The author has contributed to research in topics: Autoantibody & Fibrosis. The author has an hindex of 29, co-authored 110 publications receiving 2828 citations.

Papers
More filters
Journal ArticleDOI

CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma.

TL;DR: It is suggested that bleomycin induces fibrosis by enhancing hyaluronan production, which activates B cells to produce fibrogenic cytokines mainly via TLR4 and induce autoantibody production, and that CD19 deficiency suppresses fibrosis and autoantibia production by inhibitingTLR4 signals.
Journal ArticleDOI

Cell Adhesion Molecules Regulate Fibrotic Process via Th1/Th2/Th17 Cell Balance in a Bleomycin-Induced Scleroderma Model

TL;DR: It is suggested that L-selectin and ICAM-1 regulate Th2 and Th17 cell accumulation into the skin and lung, leading to the development of fibrosis, and that P- selectin, E-select in, and PSGL-1 regulates Th1 cell infiltration, resulting in the inhibition of fibritis.
Journal ArticleDOI

Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis

TL;DR: This study is the first to show that rapamycin has a significant inhibitory effect on fibrosis in both TSK/+ and bleomycin-induced SSc model mice, and suggests thatRapamycin might be an attractive candidate for clinical trials in SSc patients.
Journal ArticleDOI

Correlation of IgE Autoantibody to BP180 With a Severe Form of Bullous Pemphigoid

TL;DR: It is suggested that IgE anti-BP180 Abs are related to the disease severity and activity of BP, and it may be possible to identify treatment-refractory patients with BP more specifically by assessing the presence or levels of IgE against BP in those with a high IgG anti- BP180 Ab titer.